East Region Formulary
NHS Scotland

Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Buprenorphine
Espranor
Routinely available
SMC (1245/17)
29/03/2023

Indication

Substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment. Treatment with buprenorphine oral lyophilisate is intended for use in adults and adolescents aged 15 years or over who have agreed to be treated for addiction. SMC restriction: to pa...

Substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment. Treatment with buprenorphine oral lyophilisate is intended for use in adults and adolescents aged 15 years or over who have agreed to be treated for addiction. SMC restriction: to patients in whom methadone is not suitable.

Therapeutic Area

Central nervous system

Status Description

Routinely available in line with national guidance

Formulation

2mg, 8mg oral lyophilisate

Comments

-

Link to Advice

1245/17

Advice Published

12/06/2017

SMC Submission Type

Abbreviated

SMC Status

Restricted